2010 Discharge: European Medicines Agency

This procedure concerns the European Medicines Agency's (EMA) financial management for the year 2010. It involves Parliament's decision on whether the EMA correctly implemented its budget and managed its finances, ensuring accountability and transparency in its operations.

This decision affects the EMA's financial governance and reporting. It provides assurance to EU citizens that public funds are used efficiently and appropriately by the agency responsible for evaluating and supervising medicinal products.